476 related articles for article (PubMed ID: 28451776)
1. Acetylsalicylic acid-tris-hydroxymethyl-aminomethane reduces colon mucosal damage without causing gastric side effects in a rat model of colitis.
Varga G; Ugocsai M; Hartmann P; Lajkó N; Molnár R; Szűcs S; Jász DK; Érces D; Ghyczy M; Tóth G; Boros M
Inflammopharmacology; 2018 Feb; 26(1):261-271. PubMed ID: 28451776
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of topical versus oral 5-aminosalicylate for treatment of 2,4,6-trinitrobenzene sulfonic acid-induced ulcerative colitis in rats.
Li J; Chen C; Cao XN; Wang GH; Hu JB; Wang J
J Huazhong Univ Sci Technolog Med Sci; 2014 Feb; 34(1):59-65. PubMed ID: 24496680
[TBL] [Abstract][Full Text] [Related]
3. Antibiotic treatment with ampicillin accelerates the healing of colonic damage impaired by aspirin and coxib in the experimental colitis. Importance of intestinal bacteria, colonic microcirculation and proinflammatory cytokines.
Zwolinska-Wcislo M; Krzysiek-Maczka G; Ptak-Belowska A; Karczewska E; Pajdo R; Sliwowski Z; Urbanczyk K; Drozdowicz D; Konturek SJ; Pawlik WW; Brzozowski T
J Physiol Pharmacol; 2011 Jun; 62(3):357-68. PubMed ID: 21893697
[TBL] [Abstract][Full Text] [Related]
4. Reduced mucosal side-effects of acetylsalicylic acid after conjugation with tris-hydroxymethyl-aminomethane. Synthesis and biological evaluation of a new anti-inflammatory compound.
Varga G; Lajkó N; Ugocsai M; Érces D; Horváth G; Tóth G; Boros M; Ghyczy M
Eur J Pharmacol; 2016 Jun; 781():181-9. PubMed ID: 27079640
[TBL] [Abstract][Full Text] [Related]
5. Luminal antioxidants enhance the effects of mesalamine in the treatment of chemically induced colitis in rats.
Ancha HR; Kurella RR; McKimmey CC; Lightfoot S; Harty RF
Exp Biol Med (Maywood); 2008 Oct; 233(10):1301-8. PubMed ID: 18703751
[TBL] [Abstract][Full Text] [Related]
6. Therapeutic effects of rectal administration of muscovite on experimental colitis in rats.
Chen Y; Chen Y; Liu WL; Zhou TH; Cai JT; Du Q; Wang LJ; Wu JG; Si JM
J Gastroenterol Hepatol; 2009 May; 24(5):912-9. PubMed ID: 19220658
[TBL] [Abstract][Full Text] [Related]
7. The involvement of heme oxygenase-1 activity in the therapeutic actions of 5-aminosalicylic acid in rat colitis.
Horváth K; Varga C; Berkó A; Pósa A; László F; Whittle BJ
Eur J Pharmacol; 2008 Mar; 581(3):315-23. PubMed ID: 18215658
[TBL] [Abstract][Full Text] [Related]
8. In vivo efficacy of microbiota-sensitive coatings for colon targeting: a promising tool for IBD therapy.
Karrout Y; Dubuquoy L; Piveteau C; Siepmann F; Moussa E; Wils D; Beghyn T; Neut C; Flament MP; Guerin-Deremaux L; Dubreuil L; Deprez B; Desreumaux P; Siepmann J
J Control Release; 2015 Jan; 197():121-30. PubMed ID: 25445696
[TBL] [Abstract][Full Text] [Related]
9. Combined Treatment with Hyaluronic Acid and Mesalamine Protects Rats from Inflammatory Bowel Disease Induced by Intracolonic Administration of Trinitrobenzenesulfonic Acid.
Chiu CT; Kuo SN; Hung SW; Yang CY
Molecules; 2017 May; 22(6):. PubMed ID: 28556814
[TBL] [Abstract][Full Text] [Related]
10. N-methyl-D-aspartate receptor antagonist therapy suppresses colon motility and inflammatory activation six days after the onset of experimental colitis in rats.
Érces D; Varga G; Fazekas B; Kovács T; Tőkés T; Tiszlavicz L; Fülöp F; Vécsei L; Boros M; Kaszaki J
Eur J Pharmacol; 2012 Sep; 691(1-3):225-34. PubMed ID: 22796676
[TBL] [Abstract][Full Text] [Related]
11. Chitosan capsules for colon-specific drug delivery: enhanced localization of 5-aminosalicylic acid in the large intestine accelerates healing of TNBS-induced colitis in rats.
Tozaki H; Odoriba T; Okada N; Fujita T; Terabe A; Suzuki T; Okabe S; Muranishi S; Yamamoto A
J Control Release; 2002 Jul; 82(1):51-61. PubMed ID: 12106976
[TBL] [Abstract][Full Text] [Related]
12. Oenothera rosea L´Hér. ex Ait attenuates acute colonic inflammation in TNBS-induced colitis model in rats: in vivo and in silico myeloperoxidase role.
Calva-Candelaria N; Meléndez-Camargo ME; Montellano-Rosales H; Estrada-Pérez AR; Rosales-Hernández MC; Fragoso-Vázquez MJ; Martínez-Archundia M; Correa-Basurto J; Márquez-Flores YK
Biomed Pharmacother; 2018 Dec; 108():852-864. PubMed ID: 30372897
[TBL] [Abstract][Full Text] [Related]
13. Validation of a pharmacokinetic model of colon-specific drug delivery and the therapeutic effects of chitosan capsules containing 5-aminosalicylic acid on 2,4,6-trinitrobenzenesulphonic acid-induced colitis in rats.
Tozaki H; Fujita T; Odoriba T; Terabe A; Okabe S; Muranishi S; Yamamoto A
J Pharm Pharmacol; 1999 Oct; 51(10):1107-12. PubMed ID: 10579681
[TBL] [Abstract][Full Text] [Related]
14. N-Succinyl-chitosan systems for 5-aminosalicylic acid colon delivery: in vivo study with TNBS-induced colitis model in rats.
Mura C; Nácher A; Merino V; Merino-Sanjuan M; Carda C; Ruiz A; Manconi M; Loy G; Fadda AM; Diez-Sales O
Int J Pharm; 2011 Sep; 416(1):145-54. PubMed ID: 21723929
[TBL] [Abstract][Full Text] [Related]
15. Dextran-5-(4-ethoxycarbonylphenylazo)salicylic acid ester, a polymeric colon-specific prodrug releasing 5-aminosalicylic acid and benzocaine, ameliorates TNBS-induced rat colitis.
Nam J; Kim W; Lee S; Jeong S; Yoo JW; Kim MS; Jung Y
J Drug Target; 2016; 24(5):468-74. PubMed ID: 26377354
[TBL] [Abstract][Full Text] [Related]
16. Anti-tryptase treatment using nafamostat mesilate has a therapeutic effect on experimental colitis.
Isozaki Y; Yoshida N; Kuroda M; Handa O; Takagi T; Kokura S; Ichikawa H; Naito Y; Okanoue T; Yoshikawa T
Scand J Gastroenterol; 2006 Aug; 41(8):944-53. PubMed ID: 16803693
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of endogenous nitric oxide activity impairs the colonic sparing effect of rofecoxib, the cyclooxygenase-2 inhibitor and resveratrol, the preferential cyclooxygenase-1 inhibitor in the course of experimental colitis. Role of oxidative stress biomarkers and proinflammatory cytokines.
Kwiecień S; Wojcik-Grzybek D; Sliwowski Z; Targosz A; Chmura A; Magierowska K; Strzalka M; Glowacka U; Ptak-Belowska A; Magierowski M; Brzozowski T
J Physiol Pharmacol; 2023 Oct; 74(5):. PubMed ID: 38085520
[TBL] [Abstract][Full Text] [Related]
18. 1,25-hydroxyvitamin D relieves colitis in rats via down-regulation of toll-like receptor 9 expression.
Dai ZH; Tan B; Yang H; Wang O; Qian JM; Lv H
Croat Med J; 2015 Dec; 56(6):515-24. PubMed ID: 26718757
[TBL] [Abstract][Full Text] [Related]
19. Intestinal anti-inflammatory activity of hydroalcoholic extracts of Phlomis purpurea L. and Phlomis lychnitis L. in the trinitrobenzenesulphonic acid model of rat colitis.
Algieri F; Zorrilla P; Rodriguez-Nogales A; Garrido-Mesa N; Bañuelos O; González-Tejero MR; Casares-Porcel M; Molero-Mesa J; Zarzuelo A; Utrilla MP; Rodriguez-Cabezas ME; Galvez J
J Ethnopharmacol; 2013 Apr; 146(3):750-9. PubMed ID: 23395625
[TBL] [Abstract][Full Text] [Related]
20. Comparison of anti-inflammatory activities of an anthocyanin-rich fraction from Portuguese blueberries (Vaccinium corymbosum L.) and 5-aminosalicylic acid in a TNBS-induced colitis rat model.
Pereira SR; Pereira R; Figueiredo I; Freitas V; Dinis TC; Almeida LM
PLoS One; 2017; 12(3):e0174116. PubMed ID: 28329021
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
